GNTA
Genenta Science SpA - ADR

19
Mkt Cap
$61.27M
Volume
2,169.00
52W High
$6.12
52W Low
$2.56
PE Ratio
-6.44
GNTA Fundamentals
Price
$3.29
Prev Close
$3.20
Open
$3.22
50D MA
$3.30
Beta
0.12
Avg. Volume
14,495.10
EPS (Annual)
-$0.5276
P/B
4.43
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE
TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT 'ITALY ON THE MOVE 2025' SIDE EVENT DURING J.P. MORGAN HEALTHCARE...
PR Newswire·9mo ago
News Placeholder
ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE
ITALIAN TRADE AGENCY TO HOST 'ITALY ON THE MOVE 2025' SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE ITALIAN TRADE AGENCY TO HOST 'ITALY ON THE MOVE 2025' SIDE EVENT DURING J.P. MORGAN...
PR Newswire·10mo ago
News Placeholder
Genenta Science's Loyalty Shares: A Double-Edged Sword for ADS Liquidity and Investor Influence?
Genenta Science SpA Sponsored ADR (GNTA) has disclosed a new risk, in the Share Price & Shareholder Rights category. Genenta Science's proposed loy...
TipRanks Financial Blog·2y ago
News Placeholder
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
Based on Preliminary Data from Ongoing Dose Ranging Stage of the Phase 1/2 Clinical TrialMILAN, Italy and NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a...
Globe Newswire·2y ago

Latest GNTA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.